Efficacy [qlco]
Safety [hcpp]
Olmesartan medoxomil [orch, phsu]
Patients [podg]
Stage 1 [inpr]
Hypertension [dsyn]
Blood Pressure [orgf]
lowering [spco]
Goal [inpr]
Achievement [bhvr]
Hypertension [dsyn]
Known [qlco]
cardiovascular events [fndg]
Mortality [qnco]
cardiovascular events [fndg]
Age [orga]
Linear [spco]
mmHg [qnco]
Double [ftcn]
mmHg [qnco]
Elevation [topp]
Age [orga]
Guidelines [inpr]
Somewhat [inpr]
Country [geoa]
Seventh [qnco]
Report [inpr]
Joint [bsoj]
national [inpr]
Committee [grup]
Prevention [topp]
Detection [topp]
Evaluation [ftcn]
treatment [ftcn]
Blood Pressure, High [dsyn]
recommend [idcn]
Blood Pressure [orgf]
Goal [inpr]
>90 [qnco]
mmHg [qnco]
Patients [podg]
Uncomplicated Hypertension [dsyn]
mmHg [qnco]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Renal disease [dsyn]
Based [ftcn]
Patients [podg]
Stage 1 [inpr]
Hypertension [dsyn]
Seated [fndg]
cuff blood pressure [medd]
Systolic [tmco]
mmHg [qnco]
Diastolic blood pressure [clna]
>90 [qnco]
mmHg [qnco]
treated [topp]
Targeted [ftcn]
Blood Pressure [orgf]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Angiotensin II Receptor Blockers [phsu]
Well [qlco]
Blood Pressure [orgf]
reduction [npop]
Olmesartan medoxomil [orch, phsu]
Well [qlco]
Study [mnob]
Blood Pressure [orgf]
lowering [spco]
Goal [inpr]
Achievement [bhvr]
Good [qlco]
TOLERABILITY [resa]
Combination Therapy [topp]
Comprise [acty]
Olmesartan medoxomil [orch, phsu]
Plus [qlco]
Hydrochlorothiazide [orch, phsu]
Blood Pressure [orgf]
Goal [inpr]
Achievement [bhvr]
Increasing [ftcn]
adverse events [fndg]
Evaluate [ftcn]
Efficacy [qlco]
Safety [hcpp]
Olmesartan medoxomil [orch, phsu]
Based [ftcn]
Dose [qnco]
Titration Study [resa]
Factorial Study [resa]
study results [fndg]
Olmesartan medoxomil [orch, phsu]
Hydrochlorothiazide [orch, phsu]
Highly [qlco]
effective [qlco]
Reducing [qlco]
Blood Pressure [orgf]
Enabling [menp]
majority [socb]
Patients [podg]
Stage 1 [inpr]
Hypertension [dsyn]
Blood Pressure [orgf]
Goal [inpr]
Addition [ftcn]
Olmesartan medoxomil [orch, phsu]
TOLERABILITY [resa]
Achievement [bhvr]
Blood Pressure [orgf]
Goals [inpr]
expense [qnco]
Increased [qnco]
adverse events [fndg]
treatment [ftcn]
Discontinuation [hlca]
Elderly [popg]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Clinical Data [inpr]
Presented [idcn]
Support [medd]
Olmesartan medoxomil [orch, phsu]
Based [ftcn]
therapy [ftcn]
Therapeutic [topp]
Option [ftcn]
Patients [podg]
Stage 1 [inpr]
Hypertension [dsyn]
